Hypertension AI: Proving Adherence for Investor Returns
Clinicians and investors both need to know which AI vendors actually improve medication adherence for hypertension. This gets right to the heart of what ‘value’…
Healthcare AI is entering clinical practice faster than the evidence framework can evaluate it. FDA has cleared over 1,451 AI-enabled medical devices. Digital health companies are publishing clinical data at unprecedented scale. And new regulatory pathways like the Predetermined Change Control Plan (PCCP) are creating adaptive frameworks for AI that evolves after deployment.
But what does the evidence actually prove? What’s the difference between a vendor’s internal validation study and a prospective randomized controlled trial? How do you evaluate whether an AI health platform has enough clinical evidence to trust with patient care?
This guide maps the clinical AI evidence landscape — from the evidence pyramid that classifies proof quality, to the regulatory pathways governing AI devices, to the companies building the strongest (and weakest) evidence bases in digital health.
Clinicians and investors both need to know which AI vendors actually improve medication adherence for hypertension. This gets right to the heart of what ‘value’…
The combination of artificial intelligence and behavioral science is changing cardiovascular care. The promise is for earlier detection, more precise diagnostics, sustained patient engagement, and…
Hypertension is a massive, persistent problem, and it’s a leading driver of heart disease and death. AI gets a lot of hype, but clinicians and…
The article has been reviewed for time-sensitive claims. The information regarding Olive AI is outdated, as the company ceased operations in 2023. All other time-sensitive…
The real test for AI in healthcare isn’t the algorithm’s power. It’s whether patients actually engage with it. A clinically brilliant AI tool is a…
The arrival of artificial intelligence in healthcare brings massive opportunities, but it also creates thorny new problems, especially when it comes to liability. With the…
AI’s push into echocardiography could bring huge gains in diagnostic speed and accuracy, but for cardiologists and the people who run their practices, getting there…
AI in cardiac imaging is getting a lot of attention because the data volume and complexity are just overwhelming, creating a perfect opportunity for automation.…
Consumer wearables have created a new way of looking at cardiac health, giving people access to their own physiological data like never before. But this…
The idea of automated coronary artery calcium (CAC) scoring simplifying cardiovascular risk assessment is a good one, promising a more efficient and standardized diagnostic pathway.…